Company intelligence / Profile preview

Deep Origin

South San Francisco, California, United Statesdeeporigin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Deep Origin has developed an advanced computational biology platform that integrates physics-based modeling with artificial intelligence to accelerate drug discovery. Their tools enable rapid compound generation, high-fidelity prediction of efficacy, and efficient virtual screening. The Balto assistant allows scientists to perform complex simulations without deep computational expertise. Case studies show significant enrichment in identifying active compounds compared to random selection.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Not specifically listed; the company offers both direct partnerships and SaaS access to its technology.

Beyond the preview

Go deeper on Deep Origin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Origin.

Explore the full profile